Publikationen

 
Erweiterte Suche  

5867 Publikationen gefunden.

Zeitschriftenartikel

Podszun, Rupprecht Germany's Pressing Ahead: The Proposal for a reformed Competition Act CPI - Competition Policy International 2019 (gemeinsam mit Fabian Brauckmann).

 
Forschungspapiere

Drexl, Josef Technical Aspects of Artificial Intelligence: An Understanding from an Intellectual Property Law Perspective (Max Planck Institute for Innovation & Competition Research Paper, No. 19-13), 2019, 15 S. (gemeinsam mit Reto M. Hilty et al.).

 
Forschungspapiere

Finck, Michele They Who Must Not Be Identified - Distinguishing Personal from Non-Personal Data Under the GDPR (Max Planck Institute for Innovation & Competition Research Paper, No. 19-14), 2019, 48 S. (gemeinsam mit Frank Pallas).

 
Zeitschriftenartikel

Podszun, Rupprecht Intellectual property and competition law: An overview of EU and national case law e-Competitions Special Issue Intellectual Property, Antitrust Case Laws e-Bulletin, Concurrences 2019, 1 - 24 19.09.2019.

 
Wissenschaftliche Qualifikationsarbeiten

Mustafa, Zeinab Unjustified Patent Enforcement (MIPLC Master Thesis Series 2017/18) 2019, Master, MIPLC, 80 S.

 
Diskussionspapiere

Bauer, Verena; Harhoff, Dietmar; Kauermann, Göran (2019). A Smooth Dynamic Network Model for Patent Collaboration Data, arXiv preprint 1909.00736.

 
Diskussionspapiere

Gaessler, Fabian; Harhoff, Dietmar; Sorg, Stefan (2019). Bargaining Failure and Freedom to Operate: Re-Evaluating the Effect of Patents on Cumulative Innovation Max Planck Institute for Innovation & Competition Research Paper No. 19-11.

 
Diskussionspapiere

Gaessler, Fabian; Harhoff, Dietmar; Sorg, Stefan (2019). Bargaining Failure and Freedom to Operate: Re-evaluating the Effect of Patents on Cumulative Innovation CEPR Discussion Paper 13969.

 
Zeitschriftenartikel

Gonzalez Otero, Begoña Brazil joins the Madrid Protocol: A happily ever after tale? Your LATAM Flagship Blog 2019 14.08.2019.

 
Diskussionspapiere

Gaessler, Fabian; Wagner, Stefan (2019). Patents, Data Exclusivity, and the Development of New Drugs CRC Discussion Paper No. 176.